Cargando…
A pathway activity-based proteomic classifier stratifies prostate tumors into two subtypes
Prostate cancer (PCa) is the second most common cancer in males worldwide. The risk stratification of PCa is mainly based on morphological examination. Here we analyzed the proteome of 667 tumor samples from 487 Chinese PCa patients and characterized 9576 protein groups by PulseDIA mass spectrometry...
Autores principales: | Sun, Rui, Tan, Lingling, Ding, Xuan, A, Jun, Xue, Zhangzhi, Cai, Xue, Li, Sainan, Guo, Tiannan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638831/ https://www.ncbi.nlm.nih.gov/pubmed/37950160 http://dx.doi.org/10.1186/s12014-023-09441-w |
Ejemplares similares
-
Mass Spectrometry–Based Proteomics of Epithelial Ovarian Cancers: A Clinical Perspective
por: Qian, Liujia, et al.
Publicado: (2023) -
Population serum proteomics uncovers a prognostic protein classifier for metabolic syndrome
por: Cai, Xue, et al.
Publicado: (2023) -
High-throughput proteomic sample preparation using pressure cycling technology
por: Cai, Xue, et al.
Publicado: (2022) -
Proteomics Investigation of Diverse Serological Patterns in COVID-19
por: Liang, Xiao, et al.
Publicado: (2023) -
Resistance prediction in high‐grade serous ovarian carcinoma with neoadjuvant chemotherapy using data‐independent acquisition proteomics and an ovary‐specific spectral library
por: Qian, Liujia, et al.
Publicado: (2023)